When a dog starts urinating frequently, straining, or passing blood in the urine, the first assumption is almost always a urinary tract infection. That assumption is reasonable. Urinary infections are common in dogs, and the symptoms overlap almost entirely.
But when those symptoms persist despite treatment, or keep returning after courses of antibiotics, something else may be going on.
Bladder cancer in dogs is not common, but it is one of the more serious conditions that can hide behind the appearance of a recurring infection. By the time it is diagnosed, it has often been progressing quietly for months.
The most frequently occurring form is transitional cell carcinoma, known as TCC. It develops in the cells lining the bladder wall, grows into the deeper layers of bladder tissue, and in many cases partially obstructs the flow of urine. It is an aggressive cancer, but one that responds to treatment well enough to meaningfully extend a dog’s quality of life when caught and managed appropriately.
Understanding what this cancer looks like, how it is diagnosed, and what treatment involves is the starting point for every owner navigating this diagnosis. For a broader context on how cancer presents in dogs, the guide to cancer in dogs, symptoms, types, and treatment provides essential background.
What Is Bladder Cancer in Dogs?
Bladder cancer develops when the cells lining the inner surface of the urinary bladder undergo malignant transformation and begin dividing uncontrollably.
The most common form, transitional cell carcinoma, originates in the transitional epithelium, the specialised layer of cells that lines the bladder and allows it to stretch as it fills with urine. TCC accounts for the vast majority of canine bladder cancer cases. It tends to grow as a mass that invades progressively deeper into the bladder wall, eventually reaching the muscle layer and, in advanced cases, the tissue beyond.
TCC most commonly develops at the trigone, the triangular region at the base of the bladder where the ureters enter, and the urethra exits. This location is clinically significant because tumors here can obstruct one or both ureters as they grow, interfering with the flow of urine from the kidneys. They can also extend into the urethra, causing partial or complete urinary obstruction.
Less common forms of bladder cancer in dogs include leiomyosarcoma, which develops from the smooth muscle of the bladder wall, and fibrosarcoma. These are significantly rarer than TCC and behave somewhat differently, though the clinical presentation can be similar.
For a detailed look at a specific variant, the guide to urinary bladder cancer and rhabdomyosarcoma in dogs covers additional tumor types affecting the canine urinary tract.
Symptoms of Bladder Cancer in Dogs
The symptoms of bladder cancer are frustratingly similar to those of a urinary tract infection, which is precisely what makes early diagnosis so difficult.
Blood in the urine. This is one of the most common and noticeable signs. The urine may appear pink, red, or brownish, depending on the amount of blood present. While blood in the urine has many causes, its presence should always prompt veterinary investigation.
Frequent urination with small volumes. Dogs with bladder cancer often feel the urge to urinate frequently but produce only small amounts each time. The tumor creates a persistent sensation of bladder fullness even when the bladder is nearly empty.
Straining to urinate. Visible effort or discomfort during urination indicates that something is interfering with normal urine flow. This can be a sign of obstruction caused by tumor growth near the bladder outlet.
Urinary accidents indoors. A dog that is normally reliable about going outside may suddenly begin having accidents. This often reflects urgency rather than behavioural change.
Genital licking. Dogs experiencing urinary discomfort often attend to the genital area more than usual.
Recurring urinary tract infections. Bladder cancer creates an environment where bacteria can establish more easily. Many dogs with TCC are diagnosed with repeated infections that respond to antibiotics but recur shortly after treatment ends. This pattern of recurrence is an important red flag.
Lethargy and weight loss. In more advanced cases, systemic effects of the cancer become apparent through reduced energy, loss of appetite, and weight loss.
Many of these symptoms are shared with the common urinary problems in dogs that owners encounter far more frequently than cancer. This overlap is the primary reason that bladder cancer is often diagnosed later than it should be.
Causes and Risk Factors
The exact cause of bladder cancer in dogs is not fully understood. What is established is a combination of genetic and environmental factors that increase the likelihood of its development.
Breed predisposition is one of the strongest risk factors identified. Scottish Terriers are dramatically overrepresented in bladder cancer statistics, with studies suggesting they are eighteen to twenty times more likely to develop TCC than mixed-breed dogs. Beagles, Shetland Sheepdogs, West Highland White Terriers, and Wire Fox Terriers are also among the breeds with elevated risk. This clustering in specific breeds strongly suggests a genetic component.
Environmental exposures have been studied extensively in relation to bladder cancer. Exposure to certain pesticides, particularly those used on lawns, has been associated with increased TCC risk. Organophosphate and carbamate insecticides have been implicated in some research. Dogs that spend time on treated grass or in environments with chemical exposure may face an elevated risk over time.
Obesity has been suggested as a contributing factor in some studies, possibly because fat tissue stores and concentrates certain chemical compounds.
Sex appears relevant in some analyses, with females historically considered at slightly higher risk, though this is not consistent across all research.
Age is consistent with most cancers. Middle-aged to older dogs are most commonly affected, typically between six and twelve years of age.
Related Videos
How Veterinarians Diagnose Bladder Cancer
Because the symptoms of bladder cancer overlap so closely with urinary infections, diagnosis requires a stepwise clinical investigation rather than assumption.
Urinalysis. Analysis of a urine sample can reveal blood, abnormal cells, and signs of infection. A test called the BRAF mutation test, now available in some veterinary settings, can detect a specific genetic mutation found in the majority of canine TCC cases from a urine sample. This is a significant advance in non-invasive early detection.
Ultrasound. Abdominal ultrasound is one of the most useful initial imaging tools for bladder cancer. It can visualise a mass within the bladder wall, assess its size and location, and evaluate the ureters and lymph nodes for signs of obstruction or spread.
X-rays. Chest and abdominal X-rays help assess whether the cancer has spread to the lymph nodes or lungs. Contrast X-rays of the urinary tract can reveal filling defects within the bladder caused by a tumor.
Biopsy. Definitive diagnosis requires tissue confirmation. A biopsy can be obtained through cystoscopy, a minimally invasive procedure using a small camera inserted into the urethra and bladder, or through ultrasound-guided fine needle aspiration. Histopathology of the tissue sample confirms the tumor type and grade.
Blood tests. A full blood panel assesses kidney function, which may be compromised if ureteral obstruction has occurred, and evaluates the dog’s overall health for treatment planning purposes.
Given how closely bladder cancer mimics infection, any dog with recurring urinary problems that do not resolve with standard treatment should be thoroughly investigated for underlying structural causes, including cancer.
Treatment Options for Bladder Cancer in Dogs
Bladder cancer in dogs, particularly TCC, is rarely curable. The goal of treatment is to slow the progression of the disease, manage symptoms, reduce discomfort, and extend meaningful quality of life for as long as possible.
Non-steroidal anti-inflammatory drugs (NSAIDs). Piroxicam, a specific NSAID, has demonstrated genuine anti-tumor activity against TCC in dogs and is a cornerstone of medical management. It can slow tumor growth and reduce inflammation within the bladder. Some dogs show partial tumor regression on piroxicam alone. It is generally well tolerated but requires monitoring for gastrointestinal side effects.
Chemotherapy. Several chemotherapy agents have shown activity against TCC, including mitoxantrone, vinblastine, and carboplatin. These are often combined with piroxicam for improved effect. Chemotherapy extends survival and can reduce tumor burden in some dogs. It is administered by a veterinary oncologist and requires regular monitoring.
Surgery. Surgical removal of TCC tumors is limited by location. Because most TCC tumors develop at the trigone, complete removal without damaging the structures controlling urine outflow is technically very difficult. Surgery is occasionally appropriate for small tumors in favourable locations, but it is not the primary treatment for most cases.
Urinary stents and tubes. When TCC causes urethral or ureteral obstruction, stent placement may be necessary to restore urine flow. This is a palliative procedure rather than a cancer treatment, but it can significantly improve a dog’s comfort and extend the period during which quality of life remains acceptable.
Radiation therapy. This is used in some specialist centres as an adjunct treatment and has shown some effectiveness in slowing TCC progression.
Prognosis and Life Expectancy
Bladder cancer in dogs is generally not curable, but it is manageable, and that distinction matters.
With treatment, median survival times for dogs with TCC typically range from six to twelve months from the time of diagnosis, with some dogs living considerably longer. Dogs that respond well to combination therapy, piroxicam combined with chemotherapy, can achieve meaningful remission periods and maintain a good quality of life throughout.
Without treatment, the disease progresses more rapidly, and complications such as urinary obstruction can cause significant suffering within weeks to months.
The stage of disease at diagnosis influences prognosis. Dogs diagnosed before lymph node or distant metastasis has occurred generally do better than those with more advanced disease. Tumor location also matters. Tumors that have not yet caused obstruction allow more treatment options and more time.
Complications of Untreated Bladder Cancer
Allowing bladder cancer to progress without treatment carries serious consequences.
Urinary obstruction. As the tumor grows at the bladder outlet or into the urethra, it can partially or completely block the flow of urine. Partial obstruction causes painful, inefficient urination. Complete obstruction is a life-threatening emergency requiring immediate veterinary intervention.
Ureteral obstruction and kidney damage. Tumors growing at the trigone can block one or both ureters, preventing urine from draining properly from the kidneys. This causes kidney swelling, known as hydronephrosis, and progressive kidney damage.
Metastasis. TCC spreads to the regional lymph nodes in a significant proportion of cases and can further spread to the lungs, bones, and other organs. Once widespread, management becomes much more complex.
Chronic infection. Obstructed or partially obstructed urinary tracts create persistent conditions for bacterial infection. Managing recurring infections in an already compromised dog places additional strain on the body.
Significant pain and deterioration. Untreated bladder cancer causes escalating discomfort, urgency, and distress that fundamentally reduces a dog’s quality of life.
Caring for a Dog With Bladder Cancer
A diagnosis of bladder cancer changes daily routines, but with thoughtful management, affected dogs can remain comfortable and engaged for meaningful periods.
Medication adherence. Giving prescribed medications consistently and on schedule, particularly piroxicam and any chemotherapy drugs, is the single most important thing an owner can do at home.
Hydration. Encouraging good water intake dilutes urine, reduces bladder irritation, and helps flush the urinary tract. Fresh water should always be readily available.
Frequent bathroom access. A dog with bladder cancer experiences urgency and discomfort when needing to urinate. Providing regular, frequent opportunities to go outside reduces accidents and distress.
Monitoring for infection. Watch for worsening symptoms such as increased blood in the urine, foul-smelling urine, or sudden escalation in straining. These may indicate a secondary infection requiring treatment.
Comfort and routine. Dogs with serious illness benefit from predictable routines, calm environments, and consistent emotional presence. Maintaining normal activities to the degree your dog is comfortable with supports both physical and emotional well-being.
Regular veterinary check-ins. Scheduled follow-up appointments allow the veterinary team to monitor treatment response, manage side effects, and adjust the plan as the disease evolves.
When Should You See a Veterinarian?
The threshold for seeking veterinary attention when urinary symptoms are present should be low.
See your veterinarian promptly if your dog is passing blood in the urine, straining or crying during urination, urinating far more frequently than usual with small amounts each time, having indoor accidents despite being well-trained, experiencing recurring urinary infections that improve briefly then return, or showing general signs of illness such as weight loss, reduced appetite, or lethargy alongside urinary symptoms.
Do not wait through multiple rounds of antibiotics without asking whether a deeper investigation is warranted. Persistent or recurring urinary symptoms that do not respond fully to standard treatment deserve imaging and further assessment.
Early Detection Can Improve Outcomes
Bladder cancer is a serious diagnosis. But a serious diagnosis is not the same as a hopeless one.
Dogs treated promptly after diagnosis, with appropriate medical management and close veterinary oversight, can maintain a good quality of life for a year or more in many cases. The difference between a dog diagnosed early with localised disease and one diagnosed after obstruction and metastasis has occurred is significant in terms of both treatment options and outcome.
The symptoms that signal bladder cancer are not subtle. They are the same symptoms every dog owner knows to watch for in the context of urinary health. The key is not to accept recurring symptoms as simply a chronic infection problem without asking whether something more serious might be driving them.
If your dog has persistent urinary symptoms, seek veterinary assessment without delay. For a complete picture of how cancer develops and is managed across different body systems in dogs, the VOSD guide to cancer in dogs, symptoms, types, and treatment is aWhen a dog starts urinating frequently, straining, or passing blood in the urine, the first assumption is almost always a urinary tract infection. That assumption is reasonable. Urinary infections are common in dogs, and the symptoms overlap almost entirely.
But when those symptoms persist despite treatment, or keep returning after courses of antibiotics, something else may be going on.
Bladder cancer in dogs is not common, but it is one of the more serious conditions that can hide behind the appearance of a recurring infection. By the time it is diagnosed, it has often been progressing quietly for months.
The most frequently occurring form is transitional cell carcinoma, known as TCC. It develops in the cells lining the bladder wall, grows into the deeper layers of bladder tissue, and in many cases partially obstructs the flow of urine. It is an aggressive cancer, but one that responds to treatment well enough to meaningfully extend a dog’s quality of life when caught and managed appropriately.
Understanding what this cancer looks like, how it is diagnosed, and what treatment involves is the starting point for every owner navigating this diagnosis. For a broader context on how cancer presents in dogs, the guide to cancer in dogs, symptoms, types, and treatment provides essential background.
What Is Bladder Cancer in Dogs?
Bladder cancer develops when the cells lining the inner surface of the urinary bladder undergo malignant transformation and begin dividing uncontrollably.
The most common form, transitional cell carcinoma, originates in the transitional epithelium, the specialised layer of cells that lines the bladder and allows it to stretch as it fills with urine. TCC accounts for the vast majority of canine bladder cancer cases. It tends to grow as a mass that invades progressively deeper into the bladder wall, eventually reaching the muscle layer and, in advanced cases, the tissue beyond.
TCC most commonly develops at the trigone, the triangular region at the base of the bladder where the ureters enter, and the urethra exits. This location is clinically significant because tumors here can obstruct one or both ureters as they grow, interfering with the flow of urine from the kidneys. They can also extend into the urethra, causing partial or complete urinary obstruction.
Less common forms of bladder cancer in dogs include leiomyosarcoma, which develops from the smooth muscle of the bladder wall, and fibrosarcoma. These are significantly rarer than TCC and behave somewhat differently, though the clinical presentation can be similar.
For a detailed look at a specific variant, the guide to urinary bladder cancer and rhabdomyosarcoma in dogs covers additional tumor types affecting the canine urinary tract.
Symptoms of Bladder Cancer in Dogs
The symptoms of bladder cancer are frustratingly similar to those of a urinary tract infection, which is precisely what makes early diagnosis so difficult.
Blood in the urine. This is one of the most common and noticeable signs. The urine may appear pink, red, or brownish, depending on the amount of blood present. While blood in the urine has many causes, its presence should always prompt veterinary investigation.
Frequent urination with small volumes. Dogs with bladder cancer often feel the urge to urinate frequently but produce only small amounts each time. The tumor creates a persistent sensation of bladder fullness even when the bladder is nearly empty.
Straining to urinate. Visible effort or discomfort during urination indicates that something is interfering with normal urine flow. This can be a sign of obstruction caused by tumor growth near the bladder outlet.
Urinary accidents indoors. A dog that is normally reliable about going outside may suddenly begin having accidents. This often reflects urgency rather than behavioural change.
Genital licking. Dogs experiencing urinary discomfort often attend to the genital area more than usual.
Recurring urinary tract infections. Bladder cancer creates an environment where bacteria can establish more easily. Many dogs with TCC are diagnosed with repeated infections that respond to antibiotics but recur shortly after treatment ends. This pattern of recurrence is an important red flag.
Lethargy and weight loss. In more advanced cases, systemic effects of the cancer become apparent through reduced energy, loss of appetite, and weight loss.
Many of these symptoms are shared with the common urinary problems in dogs that owners encounter far more frequently than cancer. This overlap is the primary reason that bladder cancer is often diagnosed later than it should be.
Causes and Risk Factors
The exact cause of bladder cancer in dogs is not fully understood. What is established is a combination of genetic and environmental factors that increase the likelihood of its development.
Breed predisposition is one of the strongest risk factors identified. Scottish Terriers are dramatically overrepresented in bladder cancer statistics, with studies suggesting they are eighteen to twenty times more likely to develop TCC than mixed-breed dogs. Beagles, Shetland Sheepdogs, West Highland White Terriers, and Wire Fox Terriers are also among the breeds with elevated risk. This clustering in specific breeds strongly suggests a genetic component.
Environmental exposures have been studied extensively in relation to bladder cancer. Exposure to certain pesticides, particularly those used on lawns, has been associated with increased TCC risk. Organophosphate and carbamate insecticides have been implicated in some research. Dogs that spend time on treated grass or in environments with chemical exposure may face an elevated risk over time.
Obesity has been suggested as a contributing factor in some studies, possibly because fat tissue stores and concentrates certain chemical compounds.
Sex appears relevant in some analyses, with females historically considered at slightly higher risk, though this is not consistent across all research.
Age is consistent with most cancers. Middle-aged to older dogs are most commonly affected, typically between six and twelve years of age.
How Veterinarians Diagnose Bladder Cancer
Because the symptoms of bladder cancer overlap so closely with urinary infections, diagnosis requires a stepwise clinical investigation rather than assumption.
Urinalysis. Analysis of a urine sample can reveal blood, abnormal cells, and signs of infection. A test called the BRAF mutation test, now available in some veterinary settings, can detect a specific genetic mutation found in the majority of canine TCC cases from a urine sample. This is a significant advance in non-invasive early detection.
Ultrasound. Abdominal ultrasound is one of the most useful initial imaging tools for bladder cancer. It can visualise a mass within the bladder wall, assess its size and location, and evaluate the ureters and lymph nodes for signs of obstruction or spread.
X-rays. Chest and abdominal X-rays help assess whether the cancer has spread to the lymph nodes or lungs. Contrast X-rays of the urinary tract can reveal filling defects within the bladder caused by a tumor.
Biopsy. Definitive diagnosis requires tissue confirmation. A biopsy can be obtained through cystoscopy, a minimally invasive procedure using a small camera inserted into the urethra and bladder, or through ultrasound-guided fine needle aspiration. Histopathology of the tissue sample confirms the tumor type and grade.
Blood tests. A full blood panel assesses kidney function, which may be compromised if ureteral obstruction has occurred, and evaluates the dog’s overall health for treatment planning purposes.
Given how closely bladder cancer mimics infection, any dog with recurring urinary problems that do not resolve with standard treatment should be thoroughly investigated for underlying structural causes, including cancer.
Treatment Options for Bladder Cancer in Dogs
Bladder cancer in dogs, particularly TCC, is rarely curable. The goal of treatment is to slow the progression of the disease, manage symptoms, reduce discomfort, and extend meaningful quality of life for as long as possible.
Non-steroidal anti-inflammatory drugs (NSAIDs). Piroxicam, a specific NSAID, has demonstrated genuine anti-tumor activity against TCC in dogs and is a cornerstone of medical management. It can slow tumor growth and reduce inflammation within the bladder. Some dogs show partial tumor regression on piroxicam alone. It is generally well tolerated but requires monitoring for gastrointestinal side effects.
Chemotherapy. Several chemotherapy agents have shown activity against TCC, including mitoxantrone, vinblastine, and carboplatin. These are often combined with piroxicam for improved effect. Chemotherapy extends survival and can reduce tumor burden in some dogs. It is administered by a veterinary oncologist and requires regular monitoring.
Surgery. Surgical removal of TCC tumors is limited by location. Because most TCC tumors develop at the trigone, complete removal without damaging the structures controlling urine outflow is technically very difficult. Surgery is occasionally appropriate for small tumors in favourable locations, but it is not the primary treatment for most cases.
Urinary stents and tubes. When TCC causes urethral or ureteral obstruction, stent placement may be necessary to restore urine flow. This is a palliative procedure rather than a cancer treatment, but it can significantly improve a dog’s comfort and extend the period during which quality of life remains acceptable.
Radiation therapy. This is used in some specialist centres as an adjunct treatment and has shown some effectiveness in slowing TCC progression.
Related Products
Prognosis and Life Expectancy
Bladder cancer in dogs is generally not curable, but it is manageable, and that distinction matters.
With treatment, median survival times for dogs with TCC typically range from six to twelve months from the time of diagnosis, with some dogs living considerably longer. Dogs that respond well to combination therapy, piroxicam combined with chemotherapy, can achieve meaningful remission periods and maintain a good quality of life throughout.
Without treatment, the disease progresses more rapidly, and complications such as urinary obstruction can cause significant suffering within weeks to months.
The stage of disease at diagnosis influences prognosis. Dogs diagnosed before lymph node or distant metastasis has occurred generally do better than those with more advanced disease. Tumor location also matters. Tumors that have not yet caused obstruction allow more treatment options and more time.
Complications of Untreated Bladder Cancer
Allowing bladder cancer to progress without treatment carries serious consequences.
Urinary obstruction. As the tumor grows at the bladder outlet or into the urethra, it can partially or completely block the flow of urine. Partial obstruction causes painful, inefficient urination. Complete obstruction is a life-threatening emergency requiring immediate veterinary intervention.
Ureteral obstruction and kidney damage. Tumors growing at the trigone can block one or both ureters, preventing urine from draining properly from the kidneys. This causes kidney swelling, known as hydronephrosis, and progressive kidney damage.
Metastasis. TCC spreads to the regional lymph nodes in a significant proportion of cases and can further spread to the lungs, bones, and other organs. Once widespread, management becomes much more complex.
Chronic infection. Obstructed or partially obstructed urinary tracts create persistent conditions for bacterial infection. Managing recurring infections in an already compromised dog places additional strain on the body.
Significant pain and deterioration. Untreated bladder cancer causes escalating discomfort, urgency, and distress that fundamentally reduces a dog’s quality of life.
Caring for a Dog With Bladder Cancer
A diagnosis of bladder cancer changes daily routines, but with thoughtful management, affected dogs can remain comfortable and engaged for meaningful periods.
Medication adherence. Giving prescribed medications consistently and on schedule, particularly piroxicam and any chemotherapy drugs, is the single most important thing an owner can do at home.
Hydration. Encouraging good water intake dilutes urine, reduces bladder irritation, and helps flush the urinary tract. Fresh water should always be readily available.
Frequent bathroom access. A dog with bladder cancer experiences urgency and discomfort when needing to urinate. Providing regular, frequent opportunities to go outside reduces accidents and distress.
Monitoring for infection. Watch for worsening symptoms such as increased blood in the urine, foul-smelling urine, or sudden escalation in straining. These may indicate a secondary infection requiring treatment.
Comfort and routine. Dogs with serious illness benefit from predictable routines, calm environments, and consistent emotional presence. Maintaining normal activities to the degree your dog is comfortable with supports both physical and emotional well-being.
Regular veterinary check-ins. Scheduled follow-up appointments allow the veterinary team to monitor treatment response, manage side effects, and adjust the plan as the disease evolves.
When Should You See a Veterinarian?
The threshold for seeking veterinary attention when urinary symptoms are present should be low.
See your veterinarian promptly if your dog is passing blood in the urine, straining or crying during urination, urinating far more frequently than usual with small amounts each time, having indoor accidents despite being well-trained, experiencing recurring urinary infections that improve briefly then return, or showing general signs of illness such as weight loss, reduced appetite, or lethargy alongside urinary symptoms.
Do not wait through multiple rounds of antibiotics without asking whether a deeper investigation is warranted. Persistent or recurring urinary symptoms that do not respond fully to standard treatment deserve imaging and further assessment.
Early Detection Can Improve Outcomes
Bladder cancer is a serious diagnosis. But a serious diagnosis is not the same as a hopeless one.
Dogs treated promptly after diagnosis, with appropriate medical management and close veterinary oversight, can maintain a good quality of life for a year or more in many cases. The difference between a dog diagnosed early with localised disease and one diagnosed after obstruction and metastasis has occurred is significant in terms of both treatment options and outcome.
The symptoms that signal bladder cancer are not subtle. They are the same symptoms every dog owner knows to watch for in the context of urinary health. The key is not to accept recurring symptoms as simply a chronic infection problem without asking whether something more serious might be driving them.
If your dog has persistent urinary symptoms, seek veterinary assessment without delay. For a complete picture of how cancer develops and is managed across different body systems in dogs, the VOSD guide to cancer in dogs, symptoms, types, and treatment is a thorough and clinically grounded resource to guide your understanding.
Your dog cannot tell you something is wrong in words. But the signs are there. And catching them early is where better outcomes begin.
thorough and clinically grounded resource to guide your understanding.
Your dog cannot tell you something is wrong in words. But the signs are there. And catching them early is where better outcomes begin.
